MP05-16 WHAT IS THE DEFINITION OF MISCLASSIFICATION IN PATIENTS WITH GRADE GROUP 2 PROSTATE CANCER ELIGIBLE FOR ACTIVE SURVEILLANCE AND DIAGNOSED WITH MRI TARGETED BIOPSY? A MULTI-INSTITUTIONAL ANALYSIS WITH PATHOLOGICAL CONFIRMATION

Giorgio Gandaglia,Elio Mazzone,Armando Stabile,Francesco Barletta,Simone Scuderi,Daniele Robesti,Riccardo Leni,Guillaume Ploussard,Razvan George Rahota,Massimo Valerio,Riccardo Campi,Andrea Mari,Giancarlo Marra,Alessandro Marquis,Jean Baptiste Beavaul,Mathieu Roumiguié,Luca Afferi,Marco Moschini,Gontero Paolo,Hongqian Tuo,Francesco Montorsi,Alberto Briganti

MP05-16 WHAT IS THE DEFINITION OF MISCLASSIFICATION IN PATIENTS WITH GRADE GROUP 2 PROSTATE CANCER ELIGIBLE FOR ACTIVE SURVEILLANCE AND DIAGNOSED WITH MRI TARGETED BIOPSY? A MULTI-INSTITUTIONAL ANALYSIS WITH PATHOLOGICAL CONFIRMATION

2021

INTRODUCTION AND OBJECTIVE:Although PCa misclassification and progression during active surveillance (AS) have been well defined for men with low risk Prostate Cancer (PCa), the definition of adver...

Keywords:

targeted biopsy
in patient
Pathological
Medicine
Oncology
Prostate cancer
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations